Latest Articles

Publication Date
Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing - Contemporary OB/GYN

Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing Contemporary OB/GYN

Published: April 20, 2026, 4:29 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center

Published: April 20, 2026, 1 p.m.
Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test SelectScience

Published: April 20, 2026, 8:49 a.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.
Macrophage membrane-biomimetic nanovehicles delivering amygdalin halt pyroptosis propagation and alleviate endometriosis-associated neuropathic pain.

The clinical management of endometriosis encounters a significant obstacle: existing therapies inadequately address both the inhibition of ectopic lesion proliferation and the mitigation of the neuroinflammation associated with chronic pain. …

Published: April 20, 2026, midnight
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily

Published: April 18, 2026, 6:23 p.m.
Lena Dunham and the art monster - New Statesman

Lena Dunham and the art monster New Statesman

Published: April 18, 2026, 1:36 a.m.
Famesick review: Lena Dunham, art monster - New Statesman

Famesick review: Lena Dunham, art monster New Statesman

Published: April 18, 2026, 1:30 a.m.
Exploring the mechanisms of luteolin in treating polycystic ovary syndrome and endometriosis via network pharmacology, molecular docking, and molecular dynamics simulation.

This study aims to elucidate the molecular mechanisms underlying luteolin's therapeutic effects on polycystic ovary syndrome (PCOS) and endometriosis (EM), thereby providing a theoretical foundation for developing novel treatment strategies. …

Published: April 18, 2026, midnight
Polypoid endometriosis mimicking aggressive pelvic malignancy on MRI in a premenopausal woman: A case report.

Polypoid endometriosis is a rare benign variant of endometriosis characterized by exuberant mass-forming endometrial tissue that can closely mimic aggressive pelvic malignancy on imaging. Although it most commonly affects peri- …

Published: April 18, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!